Minocycline inhibits rosacea-like inflammation through the TLR4-mediated NF-kappaB signaling pathway in vivo and in vitro. Hua P, Tu Y, Yang Z, He Y, et al. PLoS One 2025;20:e0323598.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hua P, Tu Y, Yang Z, He Y, et al. Minocycline inhibits rosacea-like inflammation through the TLR4-mediated NF-kappaB signaling pathway in vivo and in vitro. PLoS One 2025;20:e0323598.
PMID: 40378103